Weight Watchers Deepens UK Clinical-Behavioral Tie with CheqUp

Event summary

  • WW International and CheqUp expanded their UK partnership on June 16, 2026, integrating clinical and behavioral weight management services.
  • UK Weight Watchers members gain direct access to CheqUp’s medical weight loss program via WW’s website.
  • CheqUp members continue receiving free access to WW’s app and Core+ program, including GLP-1 Companion support.
  • 85% of US GLP-1 Companion members report WW makes healthy living easier, per customer surveys.

The big picture

This expansion reflects the growing industry trend of combining behavioral and clinical approaches to weight management, particularly as GLP-1 medications gain broader acceptance. The partnership aligns with NHS policies expanding weight-loss medication access, positioning WW and CheqUp to capture a larger share of the UK’s medically supervised weight management market. The integration of digital health tools with clinical services represents a strategic shift toward more comprehensive, data-driven health solutions.

What we're watching

Integration Execution
How seamlessly WW and CheqUp merge clinical and behavioral services in the UK market.
GLP-1 Adoption
Whether the NHS’s expanded GLP-1 medication access will drive demand for WW’s companion services.
Market Differentiation
The pace at which this holistic model can set WW apart from competitors in the UK weight management space.